Search company, investor...

Cyplasin Biomedical

Founded Year


About Cyplasin Biomedical

Cyplasin Biomedical is a pharmaceutical company specializing in bringing new anticancer therapeutics to market. It develops and commercializes the anticancer properties of Cyplasin-SC (TM) against skin cancer and melanoma. It was founded in 2007 and is based in Edmonton, Canada.

Headquarters Location

9650 20 Ave NW, 131

Edmonton, Alberta, T6N 1G1,


Missing: Cyplasin Biomedical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Cyplasin Biomedical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Cyplasin Biomedical Frequently Asked Questions (FAQ)

  • When was Cyplasin Biomedical founded?

    Cyplasin Biomedical was founded in 2007.

  • Where is Cyplasin Biomedical's headquarters?

    Cyplasin Biomedical's headquarters is located at 9650 20 Ave NW, 131, Edmonton.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.